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Improving Folic Acid Consumption in Women at Risk for 
Neural Tube Defects in Florida  
 
 
Jessica C. Bishop-Royse, MS, Elizabeth Jensen, BA, Melanie Simmons, PhD 
 
ABSTRACT 
Two providers who participated in the Florida VitaGrant program, a site providing early childhood services to 
primarily Mexican Hispanic families (Site A) and a site providing home visiting services to pregnant women and 
families with infants (Site B), are presented as alternative models for improving folic acid levels in reproductive 
aged women in Florida.  Site A distributed multivitamins and education in the context of health education provided 
to women in a group setting, once a month.  Site B provided the services primarily through home visits of varying 
frequency.  Folic acid knowledge and consumption were measured at program initiation and at a follow-up date to 
determine levels of improvements for both sites, by demographic characteristics. Analyses comparing age, race, and 
ethnicity of women served by Site A were compared to women served by Site B.  These programs were then 
evaluated in-depth with respect to baseline and follow-up levels of folic acid knowledge and consumption of their 
participants.  Site A seemed to be somewhat more effective at improving the knowledge and consumption patterns 
of its participants than Site B, although both experienced significant improvement overall.  Initially, women who 
received services from Site A reported lower levels of baseline knowledge and multivitamin consumption than Site 
B clients.  However, Site A clients reported higher levels of knowledge and consumption at follow up than Site B 
clients. The findings suggest that free multivitamin distribution and pre/interconception education can dramatically 
increase MVC among all participants.  Program delivery that takes place in the context of a group setting may be a 
particularly effective way to reach women at-risk for neural tube defects.  
Florida Public Health Review, 2009; 6, 36-45.
Introduction 
Public health research has suggested that the 
diets of pre-conceptional women in the U.S. have 
deteriorated in the past 30 years (Putnam & Gerior, 
1999).  This may have important implications for 
some health diseases and conditions such as neural 
tube defects (which are thought to occur when 
maternal levels of folate are not adequate to support 
early neurological activity). The Centers for Disease 
Control and Prevention (CDC) have recommended 
that regardless of their intention to get pregnant, 
women of childbearing ages should consume an 
adequate amount of folate, in order to prevent neural 
tube defects (“Recommendations for folic acid,” 
1992).  Despite the fortification of many foods with 
folic acid (the synthetic form of folate, a form of B-
vitamin), current levels of dietary folate are 
inadequate for preventing neural tube defects 
(Watkin, 1998; Werler, Hayes, Louik, Shapiro, & 
Mitchell, 1999). Because folate is usually added to 
multivitamins, the CDC has recommended that all 
women aged 14-45 consume multivitamins 
containing 0.4 mg (400µg) of folic acid on a daily 
basis (“Recommendations for folic acid,” 1992).  
Some research has estimated that daily consumption 
of multivitamins (MVC) that contain folic acid can 
prevent up to 70% of NTDs (Posner et al., 2006;  
 
 
Buttriss, 2004; Czeizel & Dudás, 1992; MRC 
Vitamin Study Research Group, 1991). 
Even though folic acid supplements have been 
found to reduce the risk of neural tube defects (if 
taken prior to and in the first few weeks of 
pregnancy), a substantial proportion of women of 
childbearing age do not consume folic acid enriched 
supplements (MMWR 2008; Goldberg et al., 2006).  
Since a large proportion of pregnancies in Florida and 
the United States are unplanned (Williams et al., 
2006), women who are not taking folic acid are 
placing their unplanned pregnancies at an increased 
risk for a NTD (Atrash, Johnson, Adams, Cordero, & 
Howse, 2006). Additionally, other maternal 
characteristics also seem to be associated with higher 
occurrence of NTDs, such as young maternal age 
(aged 14-19), Hispanic ethnicity (Czeizel & Dudas, 
1992), Mexican origin (Suarez et al., 2000, Blatter et 
al., 1994), low socioeconomic status (Blatter, Van der 
Star, & Roeleveld, 1994; Eichholzer, Tonz, & 
Zimmerman, 2006; and Wasserman, Shaw, Selvin, 
Gould, & Syme, 1998) and foreign born nativity 
status (Correia & Hauser 2007). In Florida, women 
who are poor, Hispanic, non-Hispanic Black and 
younger than 25 years old are less likely to be 
consuming folic acid compared to other groups and 
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are at increased risk for having a NTD affected 
pregnancy (Florida BRFSS, 2007). 
During the period 1998-2004 in Florida, about 
one infant in every 2000 live births was born with a 
neural tube defect (NTD) such as spina bifida and 
anencephaly (Correa & Hauser, 2007). To reduce the 
occurrence of neural tube defect affected births, the 
Florida Department of Health and the March of 
Dimes Florida Chapter cooperated on a joint project, 
implementing the Florida VitaGrant Program. This 
program provided free preconception educational 
materials and multivitamins to women of 
childbearing age.   The purpose of the VitaGrant 
Program was to prevent neural tube defect affected 
births by addressing some of the socio-demographic 
factors known to be associated with NTDs, through 
education and multivitamin supplementation, which 
has been shown to be effective (Smithells, Sheppard, 
& Schorah, 1976; Slattery & Janerich, 1991; Botto, 
Moore, Khoury, & Erickson, 1999; Platzman, 1998). 
The VitaGrant Program focused on increasing 
preconception health knowledge as well as folic acid 
awareness and consumption among at-risk and 
medically underserved women of childbearing age.   
This was accomplished through preconception 
education, multivitamin distribution provider training 
and a statewide media campaign.  A unique 
component of the VitaGrant Program was that 
culturally appropriate educational materials were 
distributed to Hispanic women in order to better 
inform Spanish-speaking program participants of the 
benefits and importance of taking folic acid.  
Throughout Florida, over 265 non-profit 
organizations and agencies joined in the effort to 
distribute folic acid enriched multivitamins as well as 
preconception education materials. The partnership of 
these organizations resulted in the distribution of over 
half a million bottles of vitamins to program 
participants. 
Presented here are the findings from a process 
evaluation that assessed the improvement in folic 
acid consumption and knowledge that occurred for 
participants at two different sites, a site providing 
early childhood services to primarily Mexican 
Hispanic families (Site A) and a site providing home 
visiting services to pregnant women and families 
with infants (Site B). This evaluation was conducted 
using data collected throughout participation in the 
Florida VitaGrant Program that distributed free 
multivitamins containing folic acid and provided 
education and training for women aged 14-45 in 
Florida during the period 2005-2007. 
 
Methods 
There are several types of data that were 
generated during the course of the VitaGrant 
Program.  First, program providers collected 
information on the distribution of bottles of vitamins.  
The age, race and ethnicity of women who received 
vitamins was recorded and compiled into a 
centralized dataset that provided aggregate statistics 
to program administrators to determine how well “at-
risk” populations were reached by the program.  
VitaGrant program providers were surveyed about 
their experiences in conducting this public health 
improvement effort (combining education with 
vitamin distribution), which make up the second 
source of data. VitaGrant clients were interviewed at 
initiation and then again at follow-up, when they 
returned for services. Their answers composed the 
third source of data, which is the focus of this 
particular investigation. 
Each time VitaGrant clients were interviewed, it 
was with a program provider in the context of a 
health or social service setting. The instrument 
contained a variety of measures, which asked about 
pregnancy history, folic acid knowledge, and folic 
acid consumption as well as barriers to daily 
multivitamin consumption (MVC) and demographic 
measures such as age, ethnicity and race. At baseline, 
the knowledge item was in the form of a question 
which was posed to program participants, asking, 
“Based on what you have heard, seen or read, should 
a woman take multivitamins before her pregnancy or 
not?” To which the participants answered “Yes,” 
“No,” “Don’t Know,” and “Maybe.” The 
“consumption” item is a combination of three other 
measures; one that asked “Do you currently take 
multivitamin pills or supplements?” Another 
interview question asked, “Are any of these a 
multivitamin?” both of which were answered either 
“Yes,” “No,” or “Don’t Know/Not Sure.” Finally, a 
question that asked about the frequency of 
consumption, “How often do you take this vitamin 
pill or supplement?” The answer choices for this item 
were “Times per day ____,” “Times per week____,” 
“Times per month____,” and “Don’t know/Not 
sure____.” 
The survey was changed somewhat at follow-up 
such that the knowledge item was a checklist of 
statements that were selected if the participant 
answered affirmatively. The knowledge item asked, 
“What have you read, heard or seen about folic 
acid?” The answer choices provided were: “Prevents 
birth defects/Neural Tube Defects/Spina Bifida,” 
“Need is greater in pregnancy,” “Should be taken 
before pregnancy,” “Good for you/Good to 
take/Important,” “Important for baby development,” 
and “Don’t know.” The questions about consumption 
are as follows: “Are you currently taking the 
multivitamins provided?” and “How often?”  A 
question about barriers to daily MVC was added to 
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the follow-up survey, which asked “What are the 
challenges to taking it every day?” where the 
participants selected “Can’t remember,” “Pill too 
big,” “Makes me sick,” “Doesn’t seem important,” 




Florida ranks 4th among U.S. states with the 
largest Hispanic populations in the United States 
(Guzman, 2001).  Much of the risk for Hispanics in 
Florida stems from the fact that the majority are 
foreign-born Mexican, who have been shown to have 
increased odds of having neural tube defect births 
(Correia & Hauser, 2007).  It has been suggested that 
much of the increased risk of neural tube defect births 
for Hispanics is due to low maternal folate levels, 
perhaps driven by the diets of foreign-born women.  
Since up to 70% of neural tube defect births are 
preventable (Buttriss, 2004; Czeizel & Dudás, 1992, 
MRC Vitamin Study Research Group, 1991) with 
adequate levels of maternal folate, it would seem that 
it is in the best interest of public health practitioners 
to ensure that Hispanic women have access to an 
adequate supply of folate.   
Target Population 
Site A serves primarily Mexican-Hispanic 
families residing in and around southeast Florida.  
Most of the women who received VitaGrant Program 
services through Site A, had children who received 
early childhood education services through Site A.   
Program Description  
Site A is a non-profit, non-sectarian organization 
that provides child development services to farm 
worker families.   Mexican-origin women aged 25-29 
comprised the majority of women who received 
services at Site A. Most of the women who received 
services at Site A interacted with the program daily 
as their children received childcare services through 
the site. Additionally, women who received services 
at Site A attended monthly meetings with other 
women and program staff where they received 
education and free multivitamins.  Despite the large 
number of women who had already given birth, most 
were unaware of the preventative effects of folic acid 
when they were enrolled in the program.   
 
Results of the Program Evaluation 
Participation 
Most of the 291 women receiving services at Site 
A were between the ages of 25 and 29 years old 
(36.77%). Women older than 30 made up about 32% 
of the clients served, where women younger than 25 
comprised about 27%. Over 91 percent of the women 
served by Site A were Hispanic (the majority of 
which reported Mexican-Hispanic ethnicity).  Non-
Hispanic Whites and Blacks made up 3.44% and 
2.75% of the remaining participants. 
 




Less than 25 years old 80 27.49%
25-29 107 36.77%
Older than 30 years old 94 32.30%
Missing 10 3.44%
Total 291 100.00%
Race and Ethnicity n %
Non-Hispanic White 10 3.44%
Non-Hispanic Black 8 2.75%







Knowledge.  Table 2 shows that of the women 
who participated in the VitaGrant program through 
Site A, only 3.4% overall reported at baseline that 
they were aware of the preventative effects of folic 
acid for birth defects.  At follow up, this increased to 
over 91% who indicated that they were aware of the 
preventative effects of folic acid for birth defects. In 
terms of age, ≤ 5% or less of participants in each of 
the age groups knew that folic acid prevents NTDs. 
Knowledge increased substantially at follow-up, such 
that almost 90% of women younger than 25 years, 
89% of women ages 25 to 29 years, and about 96% of 
women age 30 and over reported improved 
knowledge. Among Hispanic women, 99% of whom 
were of Mexican-origin, only 3% reported knowledge 
at baseline. This figure increased to almost 92% at 
follow-up. 
Consumption of multivitamins (MVC).  At 
baseline, only 6.2% of Site A clients consumed 
multivitamins (Table 2). Following education and 
program participation, this increased to 87.6%. 
Additionally, women aged 30 and older were more 
likely to be taking folic acid than their younger 
counterparts at follow-up. At follow-up, non-
Hispanic Whites reported a 200% improvement in 
folic acid compliance. The improvement in folic acid 
consumption for non-Hispanic Blacks was also 
substantial, although the sample size was too small to 
demonstrate significance. At baseline all reported that 
they were not currently taking folic acid. At follow 
up, all non-Hispanic Blacks reported taking folic 
acid. Whereas Site A was successful in changing the 
knowledge and behavior of all women who received 
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services there, Hispanic women, particularly those of 
Mexican origin were particularly well served.   
Barriers 
Of the women who reported less than daily 
multivitamin consumption at Site A, over 65% said 
that the size of the pill was a factor in why they didn’t 
take the vitamin everyday (Table 3). Less than 11% 
of the women with sub-optimal multivitamin 
consumption reported that they could not remember 
to take the pill. Unknown and other reasons 
constituted 20.9% of the reasons that women did not 
take the pill daily. 
Women of all ages were likely to report the size 
of the pill as a barrier to daily multivitamin 
consumption, with women aged 25-29 more likely to 
report this as an issue than their younger and older 
peers. Remembering to take the pill was also a 
significant barrier for daily multivitamin 
consumption for older and younger women (12.5% 
and 17.6%, respectively), but not for women aged 25-
29, only 4.4% of whom reported this as a barrier. For 
the non-Hispanic Black and White women who 
received services from Site A, all (n=8) reported the 
size of the pill as a barrier to daily MVC. Among the 
Hispanic women served, over 60% reported this as a 
barrier.   
Best Practices 
The Site A model for multivitamin education and 
distribution was successful at reaching its mostly 
Mexican-Hispanic participants in large part due to the 
settings in which Site A clients received services as 
well as the provision of culturally relevant 
educational materials.  Women who received services 
at Site A participated in group educational meetings 
conducted by Spanish-speaking program providers.  
Additionally, clients interacted with the VitaGrant 
program on a near daily basis as they sought 
childcare at the facility that housed Site A services.  
The provision of culturally specific educational 
materials contributed greatly to the success of the 
VitaGrant program at this site. 
We suggest that in order to improve daily folic 
acid consumption among Hispanic women, other 
intervention programs should pay particular attention 
to the size of the multivitamins distributed.  
Distributing free multivitamins and culturally 
relevant health education materials in the context of a 
group setting seems to be an effective way to 
improve the daily folic acid consumption of Hispanic 
women. Daily interaction with the VitaGrant 
participants may also improve the folic acid 







Although Black women are not considered at 
high risk for NTDs (Bishop & Keller, 2008) as 
Mexican-Hispanic women, they have an increased 
high risk for poor infant health outcomes.  Black 
women have higher rates of preterm and low birth 
weight births and infant mortality.  As such, the 
VitaGrant sought to reach Black women with 
preconception education as well as multivitamins in 
an effort to prevent other poor birth outcomes.    
Target Population 
The population consisted of young, 
interconceptional non-Hispanic Black women 
residing in west central, Florida. These women are 
referred for services to Site B based upon the results 
of a screening tool administered thorough obstetrical 
and hospital providers.   
Program Description 
Site B is a case management agency that focuses 
on preventing low birth weight, infant mortality and 
child maltreatment. Site B serves a large proportion 
of non-Hispanic Black women less than 25 years of 
age. In general, women who received VitaGrant 
Program services from this Site were offered services 
as a part of an array of services provided, primarily 
through paraprofessionals providing home visits at 
varying intervals.  .   
 
Results of the Program Evaluation 
Participation 
The 161 women who received VitaGrant services 
through Site B were overwhelmingly young and non-
Hispanic Black (Table 4). A substantial proportion of 
women who received VitaGrant Program services at 
Site B were younger than 25 years old (47.2%). 
Women aged 25-29 made up only about 24% and 
women older than 30 made up just over 26% of those 
of who received services. Non-Hispanic Black 
women made up 60.25% of Site B participants, where 
non-Hispanic Whites and Hispanics made up 26.1% 
and 8.7%, respectively.   
Outcomes 
Knowledge. Table 5 shows that participants who 
received VitaGrant Program services at Site B 
increased their knowledge that folic acid prevents 
birth defects dramatically from baseline to follow-up.  
At baseline, all Site B participants were similarly 
uninformed about folic acid, such that about 81% did 
not know that folic acid could prevent birth defects. 
Women younger than 25 years old and older than 30 
were least likely to report awareness that folic acid 
prevented birth defects (18.4% and 19.0% 
respectively) than women aged 25-29 who were 
slightly more likely to be aware of the preventative 
effects of folic acid for birth defects (20.5%). 
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Knowledge that folic acid prevents NTDs 
increased over 183% from baseline to follow-up for 
all groups of women who received services at Site B.  
This increase was most substantial for the youngest 
women (those 24 years old and younger). At program 
onset, only about 18% of these women reported that 
they were aware of the preventative effects of folic 
acid. This increased over 236% at follow-up where 
over 79% of these women reported knowledge that 
folic acid prevents birth defects. Women aged 25-29 
and over 30 experienced improvements in knowledge 
by 236.5% and 251%, respectively. 
Whereas non-Hispanic Whites reported the 
highest levels of knowledge at follow-up (81.0% 
reporting that they were aware that folic acid prevents 
birth defects), non-Hispanic Blacks showed the 
greatest overall improvement in knowledge. The 
increase in knowledge from baseline to follow-up 
was over 408% for non-Hispanic Blacks, 299.3% for 
Hispanics and was only 183.2% for non-Hispanic 
Whites.  Whereas the improvement in knowledge for 
Hispanic women was substantial, they had the lowest 
level of knowledge at the beginning and end of the 
program, which underscores the difficulty reaching 
this high-risk population and the importance of 
delivering health education in a manner that is 
culturally specific.     
Daily consumption of multivitamins (MVC). At 
program onset, only 26% of women receiving 
services at Site B were consuming multivitamins 5-7 
days a week, which increased to almost 73% at 
follow-up (an increase of about 176%).  At baseline, 
the oldest women in the study were most likely to 
respond that they were taking folic acid 5-7 days a 
week (47.6%).  At follow-up, 66.7% of these women 
reported routine vitamin consumption (an 
improvement of only about 40%). Women aged 25-
29 were more likely to be consuming multivitamins 
at baseline and follow-up (25.6% and 76.2% 
respectively) than women younger than age 25, but 
their overall level of improvement was less than that 
of younger women. Women younger than 25 had the 
lowest levels of baseline daily MVC (15.8%) but 
experienced the greatest improvements in 
multivitamin consumption compliance at follow up, 
an improvement of over 376% to 75.3% reporting 
that they consumed multivitamins on a daily basis. 
Non-Hispanic White women were more than 
twice as likely (47.6%) to be consuming folic acid 5-
7 days a week as non-Hispanic Black (20.6%) and 
Hispanic women (14.3%) at baseline. At follow up, 
76.2% of non-Hispanic Whites, compared to 73.2% 
of non-Hispanic Blacks and 71.4% of Hispanics 
reported MVC compliance.  Whereas non-Hispanic 
Whites reported the highest levels of consumption at 
baseline and follow-up, this increase is only about 
60%. This is substantially less than the increase for 
non-Hispanic Black women (255%) and for Hispanic 
women (391%), who had the greatest improvement in 
daily MVC.    
Barriers 
The women who reported consuming 
multivitamins less than 5-7 days a week were most 
likely to cite failing to remember to do so as a barrier 
to MVC (57.1%). These women were mostly young 
and were both non-Hispanic Black and White. The 
next most often cited reason for non-compliance was 
the multivitamin pill being too big, which was an 
issue for 16.5% of the women who reported less than 
optimal multivitamin consumption. This issue was 
cited only among women less than 30 years old.  
Among the non-Hispanic White women who reported 
noncompliance, 16.7% cited this as a reason. Only 
12.7% of non-Hispanic Black women cited this 
reason for consuming multivitamins less than 5-7 
days a week. Hispanic women were twice as likely to 
report the pill being too big as a reason for non-
compliance, as any other reason. 
Best Practices 
Site B was somewhat successful at achieving 
behavior change among young non-Hispanic Black 
women. Overall, knowledge and consumption 
improved markedly for Site B participants. Timing 
devices might be an important consideration for 
improving the multivitamin consumption among non-
Hispanic Black women, of which 65.5% reported that 
remembering to take the multivitamin was a barrier to 
daily compliance.  We also recommend that the size 
of the vitamin pill be an important consideration for 
future multivitamin distribution programs, since 
clients at both sites cited it as an issue in taking 
multivitamins on a daily basis. 
 
Discussion 
Both service delivery models offered potential 
for marked improvements in the folic acid knowledge 
and multivitamin consumption patterns of its 
participants.  However, the improvements in 
multivitamin knowledge and consumption were 
substantially higher for the group setting format 
provided through Site A. At follow up, 91.8% of the 
women who received services from Site A reported 
that they were aware that folic acid prevents birth 
defects, and 87.6% reported taking folic acid 5-7 days 
a week. Site B clients reported less marked 
improvements at follow up, where 73.9% reported 
that they were aware of the preventative effects of 
folic acid, and 72.7% were taking folic acid daily.  
Notably, women who received services from Site A 
(who were mostly Mexican-Hispanic) reported low 
levels of knowledge and consumption at baseline.  
Women who received services from Site B were 
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slightly more likely to report knowledge and daily 
folic acid consumption (18.6% and 26.1% 
respectively) at baseline. 
The more diffused model of care that Site B 
clients received may be somewhat less effective at 
changing folic acid knowledge and consumption 
behaviors. Although there are strengths to the Site B 
program, the group setting model may be more 
effective at changing the folic acid knowledge and 
consumption patterns of women aged 14-45.  
Because the goal is to get women consuming 
multivitamins containing folic acid on a daily basis, it 
seems that program models that rely on the daily 
interaction of participants with the program may be 
most well suited to meet the needs of women who 
participate in such programs. Whereas Site A’s 
delivery of health care education in conjunction with 
childcare resulted in client contact on a daily basis, 
there are other ways to get women in such programs 
to interact daily with the program. These might 
include daily text message reminders, emails and 
other forms of communication that remind women to 
take their multivitamins. There may also be 
opportunities for health education messaging to be 
incorporated into other settings where health 
education has not traditionally been incorporated, like 
grocery stores, places of employment or other places 
frequented routinely by the population being sought 
to influence. 
The limitations to this study are those that are 
inherent to many program evaluations. Without a 
control group for comparison to these sites, the time-
series data can only say what the total impact of the 
media campaign, education, and the free 
multivitamins provision had on participants’ 
knowledge and behavior at follow-up. Consequently, 
it is impossible to isolate the impact of any of those 
interventions alone. Selection and reporting bias may 
have affected the findings. The program participants 
may have reported behaviors that the program 
promotes and these findings may overestimate 
knowledge and consumption of folic acid. Because 
data were available only for those women that 
remained in the program at follow-up, it is unknown 
if women who stayed in the program were more or 
less compliant than the women who dropped out. 
Despite these shortcomings, the high rates of 
overall improvement in regard to folic acid 
knowledge and consumption are comparable to other 
findings in similar projects in Utah and Western 
North Carolina (Nance, 2007, Major 2007). This 
suggests that programs that distribute both free 
multivitamins and preconception education 
(including information about folic acid) seem to 
change the knowledge and multivitamin consumption 
behaviors of the women who participate. Women 
who were not contemplating birth seem to have 
accepted the message that taking multivitamins 
improves their overall health and reduces their risk 
for having a neural tube defect affected unplanned 
pregnancy.  It might also suggest that the desire of 
some women to decrease their risk of NTD affected 
births is worth the expense of providing free 
education and multivitamins in health care and social 
service delivery. Simply put, women will consume 
multivitamins if they have access to free 
multivitamins.  
There are several strengths to the VitaGrant 
program. One is that the service delivery occurred in 
the context of overall health. Multivitamins and 
preconception educational materials were distributed 
in health care and social service settings and in many 
instances as part of a “whole health” framework. It 
seems that young women and women of Mexican 
origin, in particular, were served well by the project.  
In large part this is likely due to the efforts made by 
program administrators who distributed educational 
materials that were culturally appropriate to Hispanic 
women. This may have allowed Site A to better able 
to educate and change the behavior of Hispanic 
Women than Site B. The greater improvements for 
Hispanic women at Site A than at Site B may also be 
due to the homogeneity of Site A participants and 
staff as well as the daily interaction that occurred as 
the child care provider to women receiving VitaGrant 
services. Although Site B, whose model of service 
delivery was more diffused and included some home 
visiting with individual participants, was less 
successful than Site A in influencing behavior 
change, the model of distribution offered through the 
site still provides an effective strategy for risk 
reduction of neural tube defects. 
Preconception intervention programs may wish 
to seek out providers that offer the best chance for 
reaching and influencing the population in 
consideration. Providers that serve a diverse 
population through a diffuse array of services may 
not be as effective as those providers offering more 
intensive services at a higher frequency. Health 
education that occurs in the context of group setting 
is an effective strategy for changing the knowledge 
and behavior patterns of women at risk for poor 
health outcomes. Those interested in adopting such a 
program would be well-advised to offer a chewable 
vitamin alternative. Also, women would benefit from 
timing devices, which would help women remember 
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Table 2.  Consumption and Knowledge for Site A Participants 
 
Site A
Knowledge that folic acid prevents birth defects
Does not know if mv/folic acid prevents birth defects 96.6%** 95.00% 96.30% 100.00% 100.00% 100.00% 97.00%
n 281 76 103 94 10 8 259
Knows that mv/folic acid prevents birth defects 3.4%** 5.00% 3.70% 0.00% 0.00% 0.00% 3.00%
n 10 4 4 0 0 0 8
Total  100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
n 291 80 107 94 10 8 267
Current daily consumption
Does not consume multivitamins/folic acid 5-7 days/wk. 93.8%** 95.00% 94.40% 95.70% 60.00% 100.00% 94.80%
n 273 76 101 90 6 8 253
Currently consumes multivitamins/ folic acid 5-7 days/wk. 6.2%** 5.00% 5.60% 4.30% 40.00% 0.00% 5.20%
n 18 4 6 4 4 0 14
Total  100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
n 291 80 107 94 10 8 267
Knowledge that folic acid prevents birth defects
Does not know if mv/folic acid prevents birth defects 8.2%** 10.30% 11.20% 4.20% 20.00% 0.00% 8.20%
n 24 8 12 4 2 22
Knows that mv/folic acid prevents birth defects 91.8%** 89.70% 88.80% 95.80% 80.00% 100.00% 91.80%
n 267 70 95 92 8 8 245
Total  100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
n 291 78 107 96 10 8 267
Current daily consumption
 Does not consume multivitamins/folic acid 5-7 days/wk. 12.4%** 15.40% 16.80% 4.20% 0.00% 0.00% 13.50%
n 36 12 18 4 0 0 36
Currently consumes multivitamins/ folic acid 5-7 days/wk. 87.6%** 84.60% 83.20% 95.80% 100.00% 100.00% 86.50%
n 255 66 89 92 10 8 231
Total  100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%































Table 3.  Barriers to Compliance to Site A Participants 
 
Site A
Can't remember 10.40% 17.60% 4.40% 12.50% 0.00% 0.00% 11.90%
n 12 6 2 4 0 0 12
Pill too big 65.20% 58.80% 73.30% 62.50% 100.00% 100.00% 60.40%
n 75 20 33 20 4 8 61
Makes me sick 1.70% 5.90% 0.00% 0.00% 0.00% 0.00% 2.00%
n 2 2 0 0 0 0 2
Doesn't seem important 1.70% 0.00% 4.40% 0.00% 0.00% 0.00% 2.00%
n 2 0 2 0 0 0 2
Other and Unknown Reasons 20.90% 17.60% 17.80% 25.00% 0.00% 0.00% 23.80%
n 24 6 8 8 0 0 24
Total 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
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Table 4.  Demographic Characteristics of Site B Participants 
 
Age n %
Less than 25 years old 76 47.20%
25-29 39 24.22%
Older than 30 years old 42 26.09%
Missing 4 2.48%
Total 161 100.00%
Race and Ethnicity n %
Non-Hispanic White 42 26.09%








Table 5.  Consumption and Knowledge for Site B participants 
Site B
Knowledge that folic acid prevents birth defects
Does not know if mv/folic acid prevents birth defects 81.4%** 81.60% 79.50% 81.00% 71.40% 85.60% 85.70%
n 131 62 31 34 30 83 12
Knows that mv/folic acid prevents birth defects 18.6%** 18.40% 20.50% 19.00% 28.60% 14.40% 14.30%
n 30 14 8 8 12 14 2
Total  100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
n 161 76 39 42 42 97 14
Current daily consumption
Does not consume multivitamins/folic acid 5-7 days/wk. 73.9%** 84.20% 74.40% 52.40% 52.40% 79.40% 85.70%
n 119 64 29 22 22 77 12
Currently consumes multivitamins/ folic acid 5-7 days/wk. 26.1%** 15.80% 25.60% 47.60% 47.60% 20.60% 14.30%
n 42 12 10 20 20 20 2
Total  100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
n 161 76 39 42 42 97 14
Knowledge that folic acid prevents birth defects
Does not know if mv/folic acid prevents birth defects 26.1%** 20.50% 31.00% 33.30% 19.00% 26.80% 42.90%
n 42 15 13 14 8 26 6
Knows that mv/folic acid prevents birth defects 73.9%** 79.50% 69.00% 66.70% 81.00% 73.20% 57.10%
n 119 58 29 28 34 71 8
Total  100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
n 161 73 42 42 42 97 14
Current daily consumption
 Does not consume multivitamins/folic acid 5-7 days/wk. 27.3%** 24.70% 23.80% 33.30% 23.80% 26.80% 28.60%
n 44 18 10 14 10 26 4
Currently consumes multivitamins/ folic acid 5-7 days/wk. 72.7%** 75.30% 76.20% 66.70% 76.20% 73.20% 71.40%
n 117 55 32 28 32 71 10
Total  100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
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Table 6.  Barriers to Compliance for Site B Participants 
 
Site B
Can't remember 57.10% 71.80% 41.70% 46.20% 50.00% 65.50% 25.00%
n 52 28 10 12 12 36 2
Pill too big 16.50% 17.90% 33.30% 0.00% 16.70% 12.70% 50.00%
n 15 7 8 0 4 7 4
Makes me sick 2.20% 0.00% 0.00% 7.70% 0.00% 3.60% 0.00%
n 2 0 0 2 0 2 0
Doesn't seem important 8.80% 0.00% 8.30% 23.10% 8.30% 10.90% 0.00%
n 8 0 2 6 2 6 0
Other and Unknown Reasons 15.40% 10.30% 16.70% 23.10% 25.00% 7.30% 25.00%
n 14 4 4 6 6 4 2
Total 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
n 91 39 24 26 24 55 8
Hispanic Overall Total
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